6/12/2018

IsoPlexis collaborates with Kite Pharma to publish clinical data in Blood highlighting the potential to predict which cancer patients will respond to CAR-T cell therapy

6/12/2018

Vergent Bioscience raises $8.7 million in Series A financing led by Spring Mountain Capital

5/14/2018

IsoPlexis named as a top 10 analytics solution provider by Pharma Tech Outlook

5/7/2018

ReNetX Bio closes financing with Spring Mountain Capital

5/4/2018

OpenSlate's Mike Henry discusses importance of brand safety with Bloomberg

4/9/2018

State of Arizona selects the RiskSense platform to monitor and manage cyber security risk

3/31/2018

Maven named as a top female-founded startup that is expected to take off in 2018

3/20/2018

Home Captain closes Series A financing with Spring Mountain Capital

3/15/2018

Spring Mountain Capital leads $8 million Series B financing in 180 Health Partners

3/14/2018

Maven Clinic announces new partnership with Castlight Health to offer comprehensive parental support platform to customers

1/31/2018

ONC201 trial begins at NYU for children with H3 K27M mutant glioma

1/5/2018

Maven's Kate Ryder forecasts what will happen in women's health in 2018 in Forbes

1/3/2018

Doctor.com's David Murray shares his secrets to building great company culture in Forbes

12/13/2017

Doctor.com and Connect Healthcare announce merger to deliver the only complete solution to power the digital patient journey

12/11/2017

IsoPlexis wins 2017 Fierce Technology Innovation Award

12/1/2017

The Scientist names IsoPlexis technology the top innovation of 2017

11/15/2017

IsoPlexis receives $5.6 million in NIH funding to develop next-generation single-cell assay products, technologies and applications

10/24/2017

Maven's Katherine Ryder shares her venture capital insights

10/23/2017

IsoPlexis receives $1.8 million National Cancer Institute grant

10/13/2017

New Maven report: Why Investing in Return-to-Work Benefits is a Billion Dollar Opportunity for Companies

9/7/2017

Ad firms enlist OpenSlate to make sure ads run with "safe" YouTube videos

8/15/2017

Doctor.com launches the first universal "Web-Wide" online scheduling solution for healthcare providers

7/25/2017

Spring Mountain Capital leads $10.8 million Series A in digital health company Maven

7/25/2017

Maven lands $11 million Series A to disrupt women's health care

5/25/2017

Doctor.com and Healthgrades partner to help healthcare providers manage their online presence

5/8/2017

SimpleReach announces $13 million in funding, names MarTech veteran Hal Muchnick CEO

4/3/2017

IsoPlexis collaboration offers breakthrough insights into detecting and predicting patient response to T-cell therapy

2/23/2017

Doctor.com closes $5 million Series A financing led by Spring Mountain Capital

8/9/2016

ONC201 leads Oncoceutics to new imipridone class of cancer drugs

3/14/2016

Hurel Providing Cell-Based Models To EPA’s TOXCAST Program

2/24/2016

U.S. patent issued for ONC201 composition of matter

2/16/2016

Science Signaling companion articles describe ONC201 mechanism of action

1/19/2016

Prevalent launches Legal Vendor Network

1/11/2016

Spring Mountain Capital leads $8 million Series B financing in Prevalent

11/6/2015

IsoPlexis appoints academic and industry experts to inaugural scientific advisory board

10/22/2015

Outrigger's OpenSlate data shows a surge in ad-supported YouTube channels

10/6/2015

Spring Mountain Capital leads Series A financing for Oncoceutics

7/21/2015

Ziften announces general availability of Ziften v4.5

7/15/2015

Spring Mountain Capital leads $24 million investment in Ziften

7/9/2015

Oncoceutics announces completion of ONC201 first-in-man study

6/29/2015

Spring Mountain Capital leads new round of financing in Activate Healthcare

5/18/2015

Giga-tronics finalizes $10.0 million order for high-performance YIG tuned filter products

5/13/2015

Giga-tronics receives $3.0 million order for high-performance YIG tuned filter products

5/5/2015

Oncoceutics announces publication of a research article in the journal Molecular Cancer that describes the discovery of ONC201 as a selective anti-cancer agent

4/29/2015

Disney's Maker Studios partners with Outrigger Media to sell ads across all of YouTube

4/28/2015

Maker Studios partners with Outrigger's OpenSlate to enable advertisers to purchase ad space on all YouTube channels

4/20/2015

Optivia Biotechnology forms technology & marketing alliance with Hurel Corporation

3/31/2015

Oncoceutics awarded NCI grant for clinical trial of ONC201 in glioblastoma multiforme

3/5/2015

Experimental cancer drug from Oncoceutics could be fast-tracked, says exec

3/2/2015

Giga-tronics announces a $1.6 million strategic investment by AVI Partners, LLC and regains compliance with Nasdaq listing requirements